# ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

> **NCT06185205** · PHASE2 · RECRUITING · sponsor: **Virginia Commonwealth University** · enrollment: 170 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Accelerated partial breast irradiation

## Key facts

- **NCT ID:** NCT06185205
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-12
- **Primary completion:** 2031-01-31
- **Final completion:** 2033-01-31
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06185205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06185205, "ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06185205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*